David A. Carreno-Viveros

Best original research presented at the 27th European Congress on Gynaecological Oncology: best of ESGO 2026.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 06, 2026

Treatment strategies for oligometastatic and oligorecurrent epithelial ovarian cancer: a narrative review.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 22, 2026

Diagnostic accuracy of Chronic Kidney Disease Epidemiology Collaboration 2021 and Janowitz-estimated glomerular filtration rate for identifying renal dysfunction compared with 99mTc-DTPA in patients with locally advanced cervical cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 08, 2026

From genetic testing to prevention: an integrated clinical pathway for hereditary risk assessment in tubo-ovarian cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 25, 2026

Biomarkers guiding fertility-sparing treatment in endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 28, 2026

Highlights from the 27th European Congress on Gynecological Oncology in Copenhagen: interview compilation of the ENYGO-IJGC editorial fellows.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 12, 2026

Frequency of lymph node involvement in clinically early-stage low-grade serous ovarian cancer: a systematic review and meta-analysis.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 01, 2026

Nodal staging in endometrial cancer: quality of life, patient-reported outcomes, and survivorship.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 11, 2026

Correspondence on "Elenagen, a p62/SQSTM1-encoding plasmid, improves overall survival in patients with platinum-resistant ovarian cancer: a phase II trial" by Krasny et al.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 26, 2026

Contemporary risk assessment and risk-reducing strategies for tubo-ovarian cancer in women with BRCA pathogenic variants.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 25, 2026

Best original research presented at the 27th European Congress on Gynaecological Oncology: best of ESGO 2026.

Best original research presented at the 27th European Congress on Gynaecological Oncology: best of ESGO 2026.

Treatment strategies for oligometastatic and oligorecurrent epithelial ovarian cancer: a narrative review.

Treatment strategies for oligometastatic and oligorecurrent epithelial ovarian cancer: a narrative review.

Diagnostic accuracy of Chronic Kidney Disease Epidemiology Collaboration 2021 and Janowitz-estimated glomerular filtration rate for identifying renal dysfunction compared with 99mTc-DTPA in patients with locally advanced cervical cancer.

Diagnostic accuracy of Chronic Kidney Disease Epidemiology Collaboration 2021 and Janowitz-estimated glomerular filtration rate for identifying renal dysfunction compared with 99mTc-DTPA in patients with locally advanced cervical cancer.

From genetic testing to prevention: an integrated clinical pathway for hereditary risk assessment in tubo-ovarian cancer.

From genetic testing to prevention: an integrated clinical pathway for hereditary risk assessment in tubo-ovarian cancer.

Biomarkers guiding fertility-sparing treatment in endometrial cancer.

Biomarkers guiding fertility-sparing treatment in endometrial cancer.

Highlights from the 27th European Congress on Gynecological Oncology in Copenhagen: interview compilation of the ENYGO-IJGC editorial fellows.

Highlights from the 27th European Congress on Gynecological Oncology in Copenhagen: interview compilation of the ENYGO-IJGC editorial fellows.

Frequency of lymph node involvement in clinically early-stage low-grade serous ovarian cancer: a systematic review and meta-analysis.

Frequency of lymph node involvement in clinically early-stage low-grade serous ovarian cancer: a systematic review and meta-analysis.

Nodal staging in endometrial cancer: quality of life, patient-reported outcomes, and survivorship.

Nodal staging in endometrial cancer: quality of life, patient-reported outcomes, and survivorship.

Correspondence on "Elenagen, a p62/SQSTM1-encoding plasmid, improves overall survival in patients with platinum-resistant ovarian cancer: a phase II trial" by Krasny et al.

Correspondence on "Elenagen, a p62/SQSTM1-encoding plasmid, improves overall survival in patients with platinum-resistant ovarian cancer: a phase II trial" by Krasny et al.

Contemporary risk assessment and risk-reducing strategies for tubo-ovarian cancer in women with BRCA pathogenic variants.

Contemporary risk assessment and risk-reducing strategies for tubo-ovarian cancer in women with BRCA pathogenic variants.

Survival outcomes after inadvertent surgery in low-risk early-stage cervical cancer.

Survival outcomes after inadvertent surgery in low-risk early-stage cervical cancer.

Neoadjuvant chemotherapy in cervical cancer: a narrative review.

Neoadjuvant chemotherapy in cervical cancer: a narrative review.